Articles

  • 1 week ago | auntminnieeurope.com | Maryam Payne |Erik L. Ridley |Kelly Patrick |Vlad Kozynchenko

    Viz.ai has launched Viz 3D CTA, a new AI technology that automatically converts CT angiography (CTA) scans into high-resolution, AI-enhanced 3D images. Viz 3D CTA addresses challenges in neurovascular imaging, including delays due to manual 3D renderings, limited spatial context in PACS, and difficulty viewing smaller or more distal vessel abnormalities, the company said.

  • 1 month ago | auntminnieeurope.com | Erik L. Ridley |Maryam Payne |Kelly Patrick |Vlad Kozynchenko

    In a move aimed at expanding its breast imaging AI capabilities, imaging services provider RadNet has completed a deal to purchase AI software developer iCAD in an all-stock transaction valued at approximately $103 million (€90.5 million). RadNet will integrate iCAD into its wholly owned AI subsidiary DeepHealth. ICAD’s ProFound HealthSuite offers AI-based breast cancer detection capability for both 2D and 3D mammography as well as breast density assessment.

  • 1 month ago | auntminnieeurope.com | Erik L. Ridley |Maryam Payne |Kelly Patrick |Vlad Kozynchenko

    The Peninsula imaging network (PenRAD) has become the first U.K. imaging group to deploy Qure.ai’s AI-powered software for chest CT (qCT). The product, which is part of Qure.ai’s AI-based lung cancer suite for chest x-ray and CT, is designed to detect, measure, and track lung nodules, which may be indicative of lung cancer.

  • 1 month ago | auntminnieeurope.com | Amerigo Allegretto |Erik L. Ridley |Maryam Payne |Kelly Patrick

    Lungscreen Australia has adopted Annalise.ai’s clinical decision-support technology to provide its radiologists with AI tools with the goal of faster, more accurate diagnostics, according to the organization. The deployment of Annalise Enterprise CXR aims to help Lungscreen Australia improve diagnostic accuracy, streamline radiology workflows, and ensure faster, more precise lung disease detection for patients across the country.

  • 1 month ago | auntminnieeurope.com | Erik L. Ridley |Maryam Payne |Kelly Patrick |Vlad Kozynchenko

    AI-guided point-of-care ultrasound (POCUS) can accurately detect tuberculosis (TB), according to research presented April 14 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) conference in Vienna, Austria. In her presentation, Véronique Suttels, PhD, from Lausanne University Hospital in Switzerland discussed her team’s findings, showing that AI POCUS interpretation fulfills requirements by the World Health Organization (WHO) for a nonsputum TB triage test.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →